Strengthening Marketing Capabilities and Sales Strategy
First written in FY2022-Q1. 3 of 4 entries say "Restated". Latest entry: FY2026.
15 other companies' latest entry also says "Restated".
- FY2026RestatedAnnual report
「We will enhance our marketing capabilities and review our sales strategies in light of changes in the competitive environment arising from pharmaceutical price system reforms and changes in healthcare policy.」
市場分析、ターゲティング、MR生産性向上を含むマーケティング・営業戦略の強化方針を継続している。 - FY2022RestatedAnnual report
「We will enhance our marketing capabilities and review our sales strategies in light of changes in the competitive environment arising from pharmaceutical price system reforms and changes in healthcare policy.」
市場分析、ターゲティング、MR生産性向上を含むマーケティング・営業戦略の強化方針を継続している。 - FY2022-Q2RestatedAnnual report
「We will enhance our marketing capabilities and review our sales strategies in light of changes in the competitive environment arising from pharmaceutical price system reforms and changes in healthcare policy.」
市場分析、ターゲティング、MR生産性向上を含むマーケティング・営業戦略の強化方針を継続している。 - FY2022-Q1First statedAnnual report
「We will enhance our marketing capabilities and review our sales strategies in light of changes in the competitive environment arising from pharmaceutical price system reforms and changes in healthcare policy.」
Measures include market analysis, product selection for development, targeting and improving MR productivity.